CWM Advisors LLC Has $1.22 Million Stock Position in Agilent Technologies Inc (NYSE:A)

CWM Advisors LLC lifted its stake in Agilent Technologies Inc (NYSE:A) by 12.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,288 shares of the medical research company’s stock after buying an additional 1,807 shares during the period. CWM Advisors LLC’s holdings in Agilent Technologies were worth $1,216,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Stratos Wealth Partners LTD. raised its stake in Agilent Technologies by 2.7% during the 1st quarter. Stratos Wealth Partners LTD. now owns 31,792 shares of the medical research company’s stock valued at $2,555,000 after buying an additional 850 shares during the last quarter. TimesSquare Capital Management LLC raised its stake in Agilent Technologies by 0.7% during the 1st quarter. TimesSquare Capital Management LLC now owns 1,007,700 shares of the medical research company’s stock valued at $80,999,000 after buying an additional 7,200 shares during the last quarter. Nordea Investment Management AB raised its stake in Agilent Technologies by 510.5% during the 1st quarter. Nordea Investment Management AB now owns 112,292 shares of the medical research company’s stock valued at $9,028,000 after buying an additional 93,898 shares during the last quarter. Mason Street Advisors LLC raised its stake in Agilent Technologies by 0.8% during the 1st quarter. Mason Street Advisors LLC now owns 45,312 shares of the medical research company’s stock valued at $3,642,000 after buying an additional 370 shares during the last quarter. Finally, Envestnet Asset Management Inc. raised its stake in Agilent Technologies by 7.6% during the 1st quarter. Envestnet Asset Management Inc. now owns 144,566 shares of the medical research company’s stock valued at $11,620,000 after buying an additional 10,188 shares during the last quarter.

NYSE:A opened at $69.59 on Friday. The company has a market capitalization of $21.37 billion, a P/E ratio of 24.94, a PEG ratio of 1.88 and a beta of 1.41. The firm has a fifty day simple moving average of $70.81 and a 200-day simple moving average of $74.63. Agilent Technologies Inc has a 12 month low of $61.01 and a 12 month high of $82.27. The company has a current ratio of 3.41, a quick ratio of 2.82 and a debt-to-equity ratio of 0.35.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 14th. The medical research company reported $0.76 EPS for the quarter, topping analysts’ consensus estimates of $0.72 by $0.04. Agilent Technologies had a net margin of 22.25% and a return on equity of 19.71%. The business had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.24 billion. During the same quarter in the previous year, the company earned $0.67 earnings per share. The company’s quarterly revenue was up 5.6% on a year-over-year basis. Equities analysts forecast that Agilent Technologies Inc will post 3.05 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd were paid a dividend of $0.164 per share. This represents a $0.66 annualized dividend and a yield of 0.94%. The ex-dividend date was Monday, July 1st. Agilent Technologies’s payout ratio is currently 23.66%.

A has been the subject of several analyst reports. ValuEngine lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Friday, July 12th. Piper Jaffray Companies upped their price objective on Agilent Technologies from $83.00 to $86.00 and gave the stock an “overweight” rating in a research note on Thursday. Barclays lowered Agilent Technologies from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $86.00 to $78.00 in a research note on Monday, July 15th. Bank of America lowered Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 price objective for the company. in a research note on Tuesday, July 16th. Finally, Robert W. Baird restated an “outperform” rating and issued a $82.00 price objective (up from $79.00) on shares of Agilent Technologies in a research note on Thursday. One analyst has rated the stock with a sell rating, five have given a hold rating and ten have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $84.15.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: Are all No-Load Funds Equal?

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.